therapeutic

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

Looks like a Very bright future for small cap biotech, with so much money sitting on the table..in the hands of large companys, geared for profit and acquisitions.

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

XORTX Therapeutics Inc

shit

$XRTX ..what a nightmare since OPEN yesterday. fuck

Every stock, and I mean every fucking stock I get into shits the most epic way possible.

$XRTX this one turned into a shit show since offering

h) Pipeline with 3 assets, 2 in phase 2 is decent, for the cap of the company.

$XRTX Dr Allen Davidoff, the XORTX Therapeutics CEO, stated: “We are pleased to have achieved this important milestone in the development of XORLOTM, the Company’s proprietary oral formulation of oxypurinol.

2) Positive Top-line results on a phase 2 trial with a pivotal phase 3 application eminent.

Glad to have recently discovered it at this stage ahead of phase 3 trials.

$XRTX great pipeline with phase 3 likely to have great results for full approval.

$XRTX Am still here, will buy on dips, just time on this one with the trials going so well and good pipeline

$XRTX Great trial results will see a great share price - time will tell!

Upcoming phase three registration trial, ok cool.

bounce

$GNS  would highly recommend catching the bounce up with $XRTX this afternoon

bull

$XRTX  expect more news, better news, very soon bulls.

Jasper Therapeutics Inc

bear

$JSPR the bull that sold at 2.23 and turn bear 🐻

pump-and-dump

$JSPR   Haha, another batch of stupid longs just got trapped after the pump and dump, $2.85 to $1.85, down -35% in a day.

$JSPR  Down -25% to $2.08 on this trash stock on the dump. lol

$JSPR 
Another dump as he’s pumping 
Fkin loser

$JSPR I call these discord pumps that violative

trap

joke

wall

Jasper Therapeutics Inc also received an overall rating of 70, putting it above 70% of all stocks&quot;

gain

broke 2.50 resistance, consider locking in 59% gains from opening bell   Next 2.75 and 3

This figure makes room for additional gains of a hefty 264% over the coming year.

he already made his daily gains now he&#39;s gonna go enjoy his day. perfect

$JSPR We alerted early on #JSPR and saw a same-day MAX GAIN of 130%!

Beautiful run-up for the close of the year on $KALA , then $JSPR showed a classic run-up for a 350% gain today with $ATNF having a continuation play for a 200% plus gain over the new year!

afterhours

$LMFA ——- favorite going into next week💪Daily is primed weekly is breaking out and AH movement was insane!

Premarket Gainers: 
 
$JSPR 
+34% / 5.4 MIL VOL 
 
$GFAI 
+16.5% / 4.6 MIL VOL 
 
$ZVSA  
+70% / 3.3 MIL VOL 
 
$QBTS  
+15.5% / 2.8 MIL VOL

Gappers in premarket trading, 

$ZVSA $GROM $JSPR $APRN $ARVL 

Let’s finish the week strong! 📈✅

$HTGM 5.03$ right now and moving up in premarket.

Printed several new highs in AH and now just new high after new high. $MULN

start

$JSPR $LHDX dosent look good, u better start work here

$JSPR over 3.75 before ah starts hault up hault up hault up 🔥🔥🔥

Top Stocks matching your search for "cap therapeutics"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Oct, 17, 2022

XRTX

XORTX Therapeutics Inc

-24.19%

$0.62 - $0.47

Jan, 20, 2023

Divihomes is Now Live

JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Oct, 17, 2022

XRTX

XORTX Therapeutics Inc

-24.19%

$0.62 - $0.47

Jan, 20, 2023

JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92